Schedule 13D ownership disclosure
CALIDI BIOTHERAPEUTICS INC
Common Stock, $0.0001 par value · CUSIP: 320703408
Event date: 2026-03-09
- Filing-level shares
- 700,000.00
- Percent of class
- 9.8%
- Gavrilov Ognian AnguelovReported CIK 0002109116
Shares: 700,000.00 · Class: 9.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002109116-26-000003
- Form type
- SCHEDULE 13D
- Filer
- Calidi Biotherapeutics, Inc.
- CIK
- CIK 1855485
- Filed
- Mar 09, 2026
- Reporting period
- Mar 09, 2026
- Description
- Schedule 13D beneficial ownership